Connect with us

Health

Remdesivir Blocks Covid-19 Coronavirus, But Is It Worth The Cost? – Forbes

While WHO doesn’t recommend using remdesivir, recent studies reveal how the drug disrupts the virus.

Published

on

Remdesivir.
getty
While clinical trials suggest ‘remdesivir’ is not very effective in treating Covid-19, recent studies have shown that it does block Coronavirus activity.
That apparent contradiction makes the antiviral drug even more controversial.
Remdesivir is an experimental drug developed by biotech company Gilead Sciences (under the brand name Veklury) in collaboration with the Centres for Disease Control and Army Medical Research Institute of Infectious Diseases.
It’s one of many drug candidates…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending